Fox Jennifer A. 4
4 · Zenas BioPharma, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Fox Jennifer A.
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2024-12-16+8,125→ 8,125 totalExercise: $8.77Exp: 2034-12-15→ Common Stock (8,125 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on September 12, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service.